Morbidity and Mortality Associated With Medications Used in the Treatment of Depression: An Analysis of Cases Reported to U.S. Poison Control Centers, 2000–2014
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The authors sought to determine the relative morbidity and mortality associated with drugs used to treat depression and to examine specific clinical effects associated with serious outcomes. METHOD: The National Poison Data System, which receives exposure reports from regional poison centers serving the United States, Puerto Rico, and the District of Columbia, was queried for single drug exposures in individuals 12 years and older during the period 2000-2014. Medications included were antidepressants, atypical antipsychotics, anticonvulsants, lithium, and other medications used in the treatment of depression. The main outcomes were the morbidity index (the number of serious outcomes per 1,000 exposures) and the mortality index (the number of fatal outcomes per 10,000 exposures). RESULTS: During this 15-year period, there were 962,222 single substance exposures to the 48 medications studied. Serious outcomes rose 2.26-fold and in linear fashion over the 15 years. While tricyclic and monoamine oxidase inhibitor medications were associated with high morbidity and mortality, several newer agents also appeared hazardous. Lithium, quetiapine, olanzapine, bupropion, and carbamazepine were associated with high morbidity indices. Lithium, venlafaxine, bupropion, quetiapine, olanzapine, ziprasidone, valproic acid, carbamazepine, and citalopram were associated with higher mortality indices. CONCLUSIONS: Serious outcomes after overdose or nonintentional exposures to medications used to treat depression have risen dramatically over the past 15 years. The present data suggest that the morbidity and mortality risks vary substantially among these medications. These differences become important when selecting treatments for patients with depression, especially those at increased risk for suicide.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, the national OPPIDUM French addictovigilance network has highlighted emerging behaviour of abuse, including prescribing opioids, pregabalin and quetiapine [66].”
Citations
Cites
Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis
Cipriani, A., Hawton, K., Stockton, S., & Geddes, J. R. (2013) · BMJ · doi:10.1136/bmj.f3646 · Cited by 920
Mowry, J. B., Spyker, D. A., Cantilena, L. R., McMillan, N., & Ford, M. (2014) · Clinical Toxicology · doi:10.3109/15563650.2014.987397 · Cited by 849
Self-citationNelson, J. C., & Papakostas, G. I. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030312 · Cited by 552
Self-citationMowry, J. B., Spyker, D. A., Brooks, D. E., McMillan, N., & Schauben, J. L. (2015) · Clinical Toxicology · doi:10.3109/15563650.2015.1102927 · Cited by 507
Self-citationSuicidal Behaviour in Bipolar Disorder: Risk and Prevention
Tondo, L., Isacsson, G., & Baldessarini, R. J. (2003) · CNS Drugs · doi:10.2165/00023210-200317070-00003 · Cited by 402
Buckley, N. A., & McManus, P. R. (2002) · BMJ · doi:10.1136/bmj.325.7376.1332 · Cited by 380
Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998–2000
Cheeta, S., Schifano, F., Oyefeso, A., Webb, L., & Ghodse, A. H. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.1.41 · Cited by 284
Fatal toxicity of antidepressant drugs in overdose.
Cassidy, S., & Henry, J. (1987) · BMJ · doi:10.1136/bmj.295.6605.1021 · Cited by 249
A Review of the Cardiovascular Effects and Toxicity of Tricyclic Antidepressants
Jefferson, J. W. (1975) · Psychosomatic Medicine · doi:10.1097/00006842-197503000-00006 · Cited by 230
Mental disorders and risk of suicide attempt: a national prospective study
Hoertel, N., Franco, S., Wall, M. M., Oquendo, M. A., Kerridge, B. T., Limosin, F., & Blanco, C. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.19 · Cited by 206
Tricyclic antidepressant overdose. A review
Frommer, D. A. (1987) · JAMA · doi:10.1001/jama.257.4.521 · Cited by 196
Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose
Hawton, K., Bergen, H., Simkin, S., Cooper, J., Waters, K., Gunnell, D., & Kapur, N. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.070219 · Cited by 192
Griebeler, M. L., Morey-Vargas, O. L., Brito, J. P., Tsapas, A., Wang, Z., Carranza Leon, B. G., Phung, O. J., Montori, V. M., & Murad, M. H. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0511 · Cited by 178
Hasnain, M., & Vieweg, W. V. R. (2014) · CNS Drugs · doi:10.1007/s40263-014-0196-9 · Cited by 170
Veltri, J. C., & Litovitz, T. L. (1984) · The American Journal of Emergency Medicine · doi:10.1016/0735-6757(84)90046-9 · Cited by 133
Selle, V., Schalkwijk, S., Vázquez, G., & Baldessarini, R. (2014) · Pharmacopsychiatry · doi:10.1055/s-0033-1363258 · Cited by 128
Rubino, A., Roskell, N., Tennis, P., Mines, D., Weich, S., & Andrews, E. (2007) · BMJ · doi:10.1136/bmj.39041.445104.be · Cited by 121
Suicidal antidepressant overdoses: A comparative analysis by antidepressant type
White, N. C., Litovitz, T., & Clancy, C. (2008) · Journal of Medical Toxicology · doi:10.1007/bf03161207 · Cited by 117
Association of antipsychotic and antidepressant drugs with Q-T interval prolongation
Zemrak, W. R., & Kenna, G. A. (2008) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp070279 · Cited by 102
Risk of QT/QTc Prolongation Among Newer Non-SSRI Antidepressants
Jasiak, N. M., & Bostwick, J. R. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014550645 · Cited by 102
Litovitz, T. L., & Veltri, J. C. (1985) · The American Journal of Emergency Medicine · doi:10.1016/0735-6757(85)90203-7 · Cited by 100
Deffois, A., Fage, D., & Carter, C. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13227-4 · Cited by 97
Hall, G. C., Morant, S. V., Carroll, D., Gabriel, Z. L., & McQuay, H. J. (2013) · BMC Family Practice · doi:10.1186/1471-2296-14-28 · Cited by 96
Acute Quetiapine Overdose in Adults: A 5-Year Retrospective Case Series
Ngo, A., Ciranni, M. A., & Olson, K. R. (2008) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2008.03.016 · Cited by 93
Leonard, H. L., Meyer, M. C., Swedo, S. E., RICHTER, D., Hamburger, S. D., Allen, A. J., Rapoport, J. L., & Tucker, E. E. (1995) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199511000-00012 · Cited by 91
Bupropion exposures: clinical manifestations and medical outcome
Belson, M. G., & Kelley, T. R. (2002) · Journal of Emergency Medicine · doi:10.1016/s0736-4679(02)00522-x · Cited by 88
Toxicology and Overdose of Atypical Antipsychotics
Minns, A. B., & Clark, R. F. (2012) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2012.03.002 · Cited by 86
A systematic review of cardiovascular effects after atypical antipsychotic medication overdose
Tan, H. H., Hoppe, J. A., & Heard, K. J. (2009) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2008.04.020 · Cited by 81
Citalopram and cardiac toxicity
Cooke, M. J., & Waring, W. S. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1408-1 · Cited by 65
Overdose of Atypical Antipsychotics: Clinical Presentation, Mechanisms of Toxicity and Management
Levine, M. P., & Ruha, A. (2012) · CNS Drugs · doi:10.2165/11631640-000000000-00000 · Cited by 61
Marder, S. R., Sorsaburu, S., Dunayevich, E., Karagianis, J. L., Dawe, I. C., Falk, D. M., Dellva, M. A., Carlson, J. L., Cavazzoni, P. A., & Baker, R. W. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04411gry · Cited by 59
Papakostas, G. I., Fava, M., Baer, L., Swee, M. B., Jaeger, A., Bobo, W. V., & Shelton, R. C. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14101251 · Cited by 58
Eyer, F., Pfab, R., Felgenhauer, N., Strubel, T., Saugel, B., & Zilker, T. R. (2011) · Clinical Toxicology · doi:10.3109/15563650.2011.624100 · Cited by 58
Reichert, C., Reichert, P., Monnet-Tschudi, F., Kupferschmidt, H., Ceschi, A., & Rauber-Lüthy, C. (2014) · Clinical Toxicology · doi:10.3109/15563650.2014.918627 · Cited by 57
Why do fatal overdose rates vary between antidepressants?
Farmer, R. D. T., & Pinder, R. M. (1989) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1989.tb03044.x · Cited by 46
Hospitalized lithium overdose cases reported to theCalifornia Poison Control System
Offerman, S. R., Alsop, J. A., Lee, J. S., & Holmes, J. F. (2010) · Clinical Toxicology · doi:10.3109/15563650.2010.482533 · Cited by 43
Taylor, D., Lenox-Smith, A., & Bradley, A. (2013) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125312472890 · Cited by 35
Use of Tricyclic Antidepressants in Older Patients With Diabetic Peripheral Neuropathy
Berger, A., Dukes, E. M., Edelsberg, J., Stacey, B. R., & Oster, G. (2007) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e31802f67dd · Cited by 29
Respiratory Dysfunction in Sleep Apnea Associated with Quetiapine
Freudenmann, R. W., Süßmuth, S. D., Wolf, R. C., Stiller, P., & Schönfeldt‐Lecuona, C. (2008) · Pharmacopsychiatry · doi:10.1055/s-2008-1058111 · Cited by 22
Use of tricyclic antidepressants in older patients with painful neuropathies
Berger, A., Dukes, E. M., Edelsberg, J., Stacey, B. R., & Oster, G. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0161-8 · Cited by 18
Thinking About Dying and Trying and Intending to Die
de Araújo, R. M. F., Mazzochi, L., Lara, D. R., & Ottoni, G. L. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08864 · Cited by 14
Effects of Amitriptyline and Clomipramine in the Isolated, Perfused Rabbit Heart
Nielsen‐Kudsk, F., & Quist, S. (1980) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1980.tb02452.x · Cited by 7
Research works printed but not linked: 3
- 10.1001/jama.1987.03390040137034 · DOI
- Barbey JT, 1998, J Clin Psychiatry, 59, 42
- Hashimoto H, 1990, Arch Int Pharmacodyn Ther, 304, 181
Cited by
Li, L., Zou, D., Xiao, Z., Zeng, X., Zhang, L., Jiang, L., Wang, A., Ge, D., Zhang, G., & Liu, F. (2019) · Journal of Cleaner Production · doi:10.1016/j.jclepro.2018.11.087 · Cited by 280
Thomas, P., Lai, C. W., & Bin Johan, M. R. (2019) · Journal of Analytical and Applied Pyrolysis · doi:10.1016/j.jaap.2019.03.021 · Cited by 207
Pillinger, T., Howes, O. D., Correll, C. U., Leucht, S., Huhn, M., Schneider-Thoma, J., Gaughran, F., Jauhar, S., McGuire, P. K., Taylor, D. M., et al. (2023) · The Lancet Psychiatry · doi:10.1016/s2215-0366(23)00262-6 · Cited by 147
Xu, K. Y., Hartz, S. M., Borodovsky, J. T., Bierut, L. J., & Grucza, R. A. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.28557 · Cited by 94
Classics in Chemical Neuroscience: Amitriptyline
McClure, E. W., & Daniels, R. N. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00467 · Cited by 78
Metadata
- Authors
- Nelson, J. C., & Spyker, D. A.
- Affiliations
- Oregon Health & Science University (US)
- ORCID
- Spyker, Daniel A.
- Venue
- American Journal of Psychiatry
- Published
- 2017-05-01
- Volume
- 174
- Issue
- 5
- Pages
- 438-450
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2584620255
- Cited by
- 67
- References
- 42
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 8 · 2023: 6 · 2022: 5 · 2021: 10 · 2020: 7 · 2019: 10 · 2018: 10 · 2017: 5
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- depression treatment, antidepressants, drug overdose, poisoning, morbidity, mortality, poison control centers, tricyclic antidepressants, monoamine oxidase inhibitors, lithium, atypical antipsychotics, bupropion, quetiapine, olanzapine, carbamazepine, suicide risk, drug safety
- MeSH terms
- Adolescent, Adult, Anticonvulsants, Antidepressive Agents, Cause of Death, Child, Depressive Disorder, Female, Humans, Male, Poison Control Centers, Risk, Suicide, Antipsychotic Agents, United States, Proportional Hazards Models, Adverse Drug Reaction Reporting Systems, Lithium Compounds, Young Adult, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.